Transaction expands Ligand’s royalty portfolio to more than 200 assets and adds seven new commercial productsBolsters and diversifies Ligand’s ...
China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that, the Group through its wholly-owned subsidiary entered into an exclusive commercialization and supply agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results